Trevor McMullan
Overview
Explore the profile of Trevor McMullan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
280
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kraynyak K, Blackwood E, Agnes J, Tebas P, Giffear M, Amante D, et al.
J Infect Dis
. 2022 Jan;
225(11):1923-1932.
PMID: 35079784
Background: Additional severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines that are safe and effective as primary vaccines and boosters remain urgently needed to combat the coronavirus disease 2019 (COVID-19)...
2.
Andrade V, Christensen-Quick A, Agnes J, Tur J, Reed C, Kalia R, et al.
NPJ Vaccines
. 2021 Oct;
6(1):121.
PMID: 34650089
Global surveillance has identified emerging SARS-CoV-2 variants of concern (VOC) associated with broadened host specificity, pathogenicity, and immune evasion to vaccine-induced immunity. Here we compared humoral and cellular responses against...
3.
Vonderheide R, Kraynyak K, Shields A, McRee A, Johnson J, Sun W, et al.
J Immunother Cancer
. 2021 Jul;
9(7).
PMID: 34230114
Background: Human telomerase reverse transcriptase (hTERT) is frequently classified as a 'universal' tumor associated antigen due to its expression in a vast number of cancers. We evaluated plasmid DNA-encoded hTERT...
4.
Tebas P, Yang S, Boyer J, Reuschel E, Patel A, Christensen-Quick A, et al.
EClinicalMedicine
. 2021 Jan;
31:100689.
PMID: 33392485
Background: A vaccine against SARS-CoV-2 is of high urgency. Here the safety and immunogenicity induced by a DNA vaccine (INO-4800) targeting the full length spike antigen of SARS-CoV-2 are described....
5.
Shore N, Morrow M, McMullan T, Kraynyak K, Sylvester A, Bhatt K, et al.
Mol Ther
. 2020 Mar;
28(5):1238-1250.
PMID: 32208168
The management of men with prostate cancer (PCa) with biochemical recurrence following local definitive therapy remains controversial. Early use of androgen deprivation therapy (ADT) leads to significant side effects. Developing...
6.
Tebas P, Kraynyak K, Patel A, Maslow J, Morrow M, Sylvester A, et al.
J Infect Dis
. 2019 Mar;
220(3):400-410.
PMID: 30891607
Background: Nonlive vaccine approaches that are simple to deliver and stable at room temperature or 2-8°C could be advantageous in controlling future Ebola virus (EBOV) outbreaks. Using an immunopotent DNA...